Cardiovascular Risk Highest in Mothers with Hypertension, Diabetes, or Both: Study

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-09-19 02:45 GMT   |   Update On 2025-09-19 02:45 GMT
Advertisement

A new study has determined that mothers who experienced pre-pregnancy hypertension, hypertensive disorders of pregnancy (HDP), diabetes, or any combination of these three diseases are at greatly elevated risks of coronary heart disease (CHD) and all-cause mortality in the first five years postpartum. The study was published in BMC Cardiovascular Diabetology journal by Angela M. and fellow researchers. These results underscore the imperative to better screen for risk factors and provide follow-up care for such women, particularly in racial groups that are disproportionately affected.

Advertisement

This retrospective cohort analysis examined information from 430,545 women aged 12–49 with at least one singleton live birth in South Carolina during 2004–2016. The cohort consisted of 59.2% non-Hispanic White (NHW), 31.4% non-Hispanic Black (NHB), and 9.4% Hispanic women. Birth certificate and hospitalization/emergency department (ED) data were used to determine women with pre-pregnancy hypertension, HDP (preeclampsia, eclampsia, and gestational hypertension), and pre-pregnancy and gestational diabetes. Incident CHD and all-cause mortality were followed through hospitalization/ED and death certificate records over a follow-up duration of up to 14 years.

The Cox proportional hazard models were utilized to estimate the adjusted risk of CHD and all-cause death according to the presence of individual or combined conditions (diabetes, HDP, pre-pregnancy hypertension). The aim was to evaluate the independent and cumulative effect of such conditions on maternal cardiovascular outcomes at 5 years post-delivery and during the full duration of the study. The analysis was also controlled for age, race, and other complications and comorbidities at delivery.

Key Findings

Within five years of giving birth, women with any one of the three maternal conditions were at significantly higher risk of developing coronary heart disease:

  • Diabetes on its own was linked with a 57% increased risk of CHD (HR = 1.57; 95% CI: 1.28–1.92).

  • HDP on its own increased the risk by 85% (HR = 1.85; 95% CI: 1.60–2.15).

  • Both HDP and diabetes were associated with a 129% increased risk (HR = 2.29; 95% CI: 1.73–3.03).

  • HDP with pre-pregnancy hypertension had a 213% increased risk (HR = 3.13; 95% CI: 2.66–3.68).

  • Women with all three conditions had an almost five-fold higher risk (HR = 4.87; 95% CI: 3.95–6.01).

In the analysis of all-cause mortality at five years:

  • Diabetes alone had a 34% increased risk (HR = 1.34; 95% CI: 1.01–1.78).

  • HDP with pre-pregnancy hypertension had a 53% increased risk (HR = 1.53; 95% CI: 1.15–2.03).

  • All three conditions together were associated with a 125% higher risk of death (HR = 2.25; 95% CI: 1.51–3.36).

  • HDP alone or HDP with diabetes did not have statistically significant higher mortality risk.

This large-scale investigation offers strong evidence that the co-existence and concomitance of diabetes, pre-pregnancy hypertension, and hypertensive disorders during pregnancy excessively raise the risk of coronary heart disease development and all-cause mortality in subsequent years post-childbirth.

Reference:

Malek, A.M., Wilson, D.A., Mateus, J. et al. Maternal coronary heart disease and mortality following hypertensive disorders of pregnancy and/or diabetes. Cardiovasc Diabetol 24, 282 (2025). https://doi.org/10.1186/s12933-025-02811-8



Tags:    
Article Source : BMC Cardiovascular Diabetology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News